Literature DB >> 23308041

Opening Pandora's jar: a primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders.

Rajesh Khanna1, Sarah M Wilson, Joel M Brittain, Jill Weimer, Rukhsana Sultana, Allan Butterfield, Kenneth Hensley.   

Abstract

CRMP2, also known as DPYSL2/DRP2, Unc-33, Ulip or TUC2, is a cytosolic phosphoprotein that mediates axon/dendrite specification and axonal growth. Mapping the CRMP2 interactome has revealed previously unappreciated functions subserved by this protein. Together with its canonical roles in neurite growth and retraction and kinesin-dependent axonal transport, it is now known that CRMP2 interacts with numerous binding partners to affect microtubule dynamics; protein endocytosis and vesicular cycling, synaptic assembly, calcium channel regulation and neurotransmitter release. CRMP2 signaling is regulated by post-translational modifications, including glycosylation, oxidation, proteolysis and phosphorylation; the latter being a fulcrum of CRMP2 functions. Here, the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders are discussed and evidence is presented for therapeutic strategies targeting CRMP2 functions.

Entities:  

Year:  2012        PMID: 23308041      PMCID: PMC3539824          DOI: 10.2217/FNL.12.68

Source DB:  PubMed          Journal:  Future Neurol        ISSN: 1479-6708


  210 in total

1.  Neuron-specific phosphorylation of Alzheimer's beta-amyloid precursor protein by cyclin-dependent kinase 5.

Authors:  K Iijima; K Ando; S Takeda; Y Satoh; T Seki; S Itohara; P Greengard; Y Kirino; A C Nairn; T Suzuki
Journal:  J Neurochem       Date:  2000-09       Impact factor: 5.372

Review 2.  Lacosamide.

Authors:  Pamela Doty; G David Rudd; Thomas Stoehr; Dirk Thomas
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

Review 3.  On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.

Authors:  Kenneth Hensley; Molina Mhatre; Shenyun Mou; Quentin N Pye; Charles Stewart; Melinda West; Kelly S Williamson
Journal:  Antioxid Redox Signal       Date:  2006 Nov-Dec       Impact factor: 8.401

4.  A novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseases.

Authors:  Krishnakumar N Menon; David L Steer; Martin Short; Steven Petratos; Ian Smith; Claude C A Bernard
Journal:  Mol Cell Proteomics       Date:  2011-03-18       Impact factor: 5.911

5.  The memory enhancing effect of the APP-derived tripeptide Ac-rER is mediated through CRMP2.

Authors:  Radmila Mileusnic; Steven P R Rose
Journal:  J Neurochem       Date:  2011-02-24       Impact factor: 5.372

Review 6.  Increased CRMP2 phosphorylation is observed in Alzheimer's disease; does this tell us anything about disease development?

Authors:  M P M Soutar; P Thornhill; A R Cole; C Sutherland
Journal:  Curr Alzheimer Res       Date:  2009-06       Impact factor: 3.498

7.  Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases.

Authors:  Joungil Choi; Allan I Levey; Susan T Weintraub; Howard D Rees; Marla Gearing; Lih-Shen Chin; Lian Li
Journal:  J Biol Chem       Date:  2004-01-13       Impact factor: 5.157

8.  The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.

Authors:  Adam C Errington; Thomas Stöhr; Cara Heers; George Lees
Journal:  Mol Pharmacol       Date:  2007-10-16       Impact factor: 4.436

9.  Location and connectivity determine GABAergic interneuron survival in the brains of South Hampshire sheep with CLN6 neuronal ceroid lipofuscinosis.

Authors:  Manfred J Oswald; David N Palmer; Graham W Kay; Karen J Barwell; Jonathan D Cooper
Journal:  Neurobiol Dis       Date:  2008-06-25       Impact factor: 5.996

10.  Retention of lysosomal protein CLN5 in the endoplasmic reticulum causes neuronal ceroid lipofuscinosis in Asian sibship.

Authors:  Anne-Hélène Lebrun; Stephan Storch; Franz Rüschendorf; Mia-Lisa Schmiedt; Aija Kyttälä; Sara E Mole; Claudia Kitzmüller; Kathrin Saar; Leena D Mewasingh; Volker Boda; Alfried Kohlschütter; Kurt Ullrich; Thomas Braulke; Angela Schulz
Journal:  Hum Mutat       Date:  2009-05       Impact factor: 4.878

View more
  50 in total

1.  (S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5.

Authors:  Aubin Moutal; Liberty François-Moutal; Samantha Perez-Miller; Karissa Cottier; Lindsey Anne Chew; Seul Ki Yeon; Jixun Dai; Ki Duk Park; May Khanna; Rajesh Khanna
Journal:  Mol Neurobiol       Date:  2015-04-07       Impact factor: 5.590

2.  Phosphorylated CRMP2 Regulates Spinal Nociceptive Neurotransmission.

Authors:  Jie Yu; Aubin Moutal; Angie Dorame; Shreya S Bellampalli; Aude Chefdeville; Iori Kanazawa; Nancy Y N Pham; Ki Duk Park; Jill M Weimer; Rajesh Khanna
Journal:  Mol Neurobiol       Date:  2018-12-18       Impact factor: 5.590

3.  A single structurally conserved SUMOylation site in CRMP2 controls NaV1.7 function.

Authors:  Erik Thomas Dustrude; Samantha Perez-Miller; Liberty François-Moutal; Aubin Moutal; May Khanna; Rajesh Khanna
Journal:  Channels (Austin)       Date:  2017-02-28       Impact factor: 2.581

4.  Transcriptional regulation of CRMP5 controls neurite outgrowth through Sox5.

Authors:  Nicolas Naudet; Aubin Moutal; Hong Nhung Vu; Naura Chounlamountri; Chantal Watrin; Sylvie Cavagna; Céline Malleval; Claire Benetollo; Claire Bardel; Marie-Aimée Dronne; Jérôme Honnorat; Claire Meissirel; Roger Besançon
Journal:  Cell Mol Life Sci       Date:  2017-09-01       Impact factor: 9.261

5.  Proteomic analysis of six- and twelve-month hippocampus and cerebellum in a murine Down syndrome model.

Authors:  Guido N Vacano; David S Gibson; Abdullah Arif Turjoman; Jeremy W Gawryluk; Jonathan D Geiger; Mark Duncan; David Patterson
Journal:  Neurobiol Aging       Date:  2017-11-26       Impact factor: 4.673

6.  Blocking CRMP2 SUMOylation reverses neuropathic pain.

Authors:  A Moutal; E T Dustrude; T M Largent-Milnes; T W Vanderah; M Khanna; R Khanna
Journal:  Mol Psychiatry       Date:  2018-11       Impact factor: 15.992

7.  UBC9 regulates cardiac sodium channel Nav1.5 ubiquitination, degradation and sodium current density.

Authors:  Bo Tang; Yushuang Hu; Zhijie Wang; Chen Cheng; Pengyun Wang; Lina Liang; Hongbo Xiong; Chunyan Luo; Chengqi Xu; Qiuyun Chen; Qing Kenneth Wang
Journal:  J Mol Cell Cardiol       Date:  2019-02-14       Impact factor: 5.000

Review 8.  Neuronal networks in mental diseases and neuropathic pain: Beyond brain derived neurotrophic factor and collapsin response mediator proteins.

Authors:  Tam T Quach; Jessica K Lerch; Jerome Honnorat; Rajesh Khanna; Anne-Marie Duchemin
Journal:  World J Psychiatry       Date:  2016-03-22

9.  CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking.

Authors:  Erik T Dustrude; Sarah M Wilson; Weina Ju; Yucheng Xiao; Rajesh Khanna
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

Review 10.  Mining the Nav1.7 interactome: Opportunities for chronic pain therapeutics.

Authors:  Lindsey A Chew; Shreya S Bellampalli; Erik T Dustrude; Rajesh Khanna
Journal:  Biochem Pharmacol       Date:  2019-01-27       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.